Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.01552
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Metabolic Reprogramming in Mitochondria of Myeloid Cells

Cells
2019English

A Dynamic Metabolic Flux Analysis of Myeloid-Derived Suppressor Cells Confirms Immunosuppression-Related Metabolic Plasticity

Scientific Reports
Multidisciplinary
2017English

Nrf2: Redox and Metabolic Regulator of Stem Cell State and Function

Trends in Molecular Medicine
Molecular MedicineMolecular Biology
2020English

Myeloid-Derived Suppressor Cells in Autoimmune Diseases

Inflammation and Regeneration
AllergyImmunology
2014English

Nicotinamide Phosphoribosyltransferase (NAMPT) Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells

Cancer Research
Cancer ResearchOncology
2019English

Myeloid-Derived Suppressor Cells and Myeloid Regulatory Cells in Cancer and Autoimmune Disorders

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

EWS/FLI Is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2017English

Targeting Myeloid-Derived Suppressor Cells in the Treatment of Hepatocellular Carcinoma: Current State and Future Perspectives

Journal of Hepatocellular Carcinoma
2019English

A Novel CD48-Based Analysis of Sepsis-Induced Mouse Myeloid-Derived Suppressor Cell Compartments

Mediators of Inflammation
ImmunologyCell Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy